Amin, Dhara N <br/><br/>
Resiliency and vulnerability in the HER2-HER3 tumorigenic driver.  [electronic resource] 

 -  Science translational medicine  Jan 2010 
 - 16ra7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1946-6242 
<br/><br/><label>Standard No.: </label>10.1126/scitranslmed.3000389  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line, Tumor<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Humans<br/>Imidazoles--pharmacology<br/>Lapatinib<br/>Mice<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Neoplasms--drug therapy<br/>Protein Multimerization--drug effects<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Quinazolines--pharmacology<br/>Quinolines--pharmacology<br/>Receptor, ErbB-2--metabolism<br/>Receptor, ErbB-3--metabolism<br/>Signal Transduction--drug effects